E. S. K. Dogan And N. DURAN, "Is periodontal inflamed surface area associated with serum and salivary levels of IL-1β, visfatin, and omentin-1 in overweight/obese patients?," CLINICAL ORAL INVESTIGATIONS , no.8, pp.5351-5358, 2022
Dogan, E. S. K. And DURAN, N. 2022. Is periodontal inflamed surface area associated with serum and salivary levels of IL-1β, visfatin, and omentin-1 in overweight/obese patients?. CLINICAL ORAL INVESTIGATIONS , no.8 , 5351-5358.
Dogan, E. S. K., & DURAN, N., (2022). Is periodontal inflamed surface area associated with serum and salivary levels of IL-1β, visfatin, and omentin-1 in overweight/obese patients?. CLINICAL ORAL INVESTIGATIONS , no.8, 5351-5358.
Dogan, Esra, And NİZAMİ DURAN. "Is periodontal inflamed surface area associated with serum and salivary levels of IL-1β, visfatin, and omentin-1 in overweight/obese patients?," CLINICAL ORAL INVESTIGATIONS , no.8, 5351-5358, 2022
Dogan, Esra S. And DURAN, NİZAMİ. "Is periodontal inflamed surface area associated with serum and salivary levels of IL-1β, visfatin, and omentin-1 in overweight/obese patients?." CLINICAL ORAL INVESTIGATIONS , no.8, pp.5351-5358, 2022
Dogan, E. S. K. And DURAN, N. (2022) . "Is periodontal inflamed surface area associated with serum and salivary levels of IL-1β, visfatin, and omentin-1 in overweight/obese patients?." CLINICAL ORAL INVESTIGATIONS , no.8, pp.5351-5358.
@article{article, author={Esra Sinem Kemer Dogan And author={NİZAMİ DURAN}, title={Is periodontal inflamed surface area associated with serum and salivary levels of IL-1β, visfatin, and omentin-1 in overweight/obese patients?}, journal={CLINICAL ORAL INVESTIGATIONS}, year=2022, pages={5351-5358} }